Form 4: Zoetis Director Frank D'Amelio Receives RSU Grant

Zoetis Inc. Director Frank A. D'Amelio was granted 1,936 restricted stock units, which are scheduled to vest on February 18, 2026.

Summary

• Frank A. D'Amelio, a Director of Zoetis Inc. (ZTS), acquired 1,936 Restricted Stock Units (RSUs) on February 18, 2026.
• These 1,936 RSUs are scheduled to vest and be settled in shares of Zoetis Inc. common stock on February 18, 2026, subject to continued service.
• The reporting person also beneficially owns 1,619.3325 Restricted Stock Units that vested on February 19, 2025.
• The RSUs were granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, including dividend equivalent units.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive signal, indicating continued alignment of director interests with shareholder value through equity compensation, which is a standard corporate practice.

Positives

• The grant of equity aligns the director's interests with those of shareholders, promoting long-term value creation.

Risks

• The vesting of the 1,936 Restricted Stock Units is subject to the reporting person's continued service through the vesting date of February 18, 2026.

Future Outlook

The filing indicates future settlement of 1,936 Restricted Stock Units into common stock on February 18, 2026, contingent on the director's continued service.

Industry Context

StockSavvy.ai notes that equity grants to directors are a standard practice in corporate governance, aligning executive and director interests with those of shareholders by tying compensation to company performance. This is a routine disclosure for such compensation.

Comparison to Industry Standards

• Equity grants to directors are a common compensation practice across industries, including the pharmaceutical and animal health sectors where Zoetis operates.
• Companies like Merck (MRK) and Elanco Animal Health (ELAN) also utilize similar equity incentive plans to retain and motivate key personnel.
• The specific number of units granted is relative to the individual's role and the company's compensation philosophy, and this grant is consistent with typical director compensation structures.

Corporate Governance

Stakeholder Impact

• Shareholders: Interests are further aligned with the director through equity ownership, potentially fostering long-term value creation.

Next Steps

• Settlement of 1,936 Restricted Stock Units into common stock on February 18, 2026, upon vesting.

Key Dates

Recommendation

This Form 4 reports a routine equity grant to a director, which is a standard compensation practice and does not typically indicate a significant change in the company's fundamental outlook or warrant a change in investment recommendation. It reinforces alignment but is not a catalyst for a buy or sell decision.

Keywords

Zoetis, ZTS, Form 4, Insider Transaction, Restricted Stock Units, RSU, Equity Grant, Director, Frank D'Amelio